Home » Clinical Practice Alert: For Entecavir and Vancomycin use

Clinical Practice Alert: For Entecavir and Vancomycin use

On 24-Feb-2007, FDA included entecavir in MedWatch [Excerpt: Current treatment guidelines recommend Baraclude as an option for treatment of HBV in the HIV/HBV co-infected adult patient who does not qualify for HAART.

Visit original post at Samir Amin

Leave a Comment